Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

SELL
$2.07 - $4.54 $12,759 - $27,984
-6,164 Reduced 96.51%
223 $0
Q2 2023

Aug 14, 2023

SELL
$4.25 - $5.88 $195 - $270
-46 Reduced 0.72%
6,387 $29,000
Q4 2022

Feb 13, 2023

BUY
$5.41 - $8.08 $17,934 - $26,785
3,315 Added 106.32%
6,433 $51,000
Q3 2022

Nov 14, 2022

SELL
$5.17 - $7.11 $1.42 Million - $1.95 Million
-274,642 Reduced 98.88%
3,118 $17,000
Q2 2022

Aug 15, 2022

BUY
$3.41 - $8.95 $947,161 - $2.49 Million
277,760 New
277,760 $1.45 Million
Q1 2022

May 13, 2022

SELL
$7.78 - $15.31 $7,110 - $13,993
-914 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$14.25 - $23.53 $16,530 - $27,294
-1,160 Reduced 55.93%
914 $14,000
Q3 2021

Nov 15, 2021

SELL
$16.88 - $22.38 $253 - $335
-15 Reduced 0.72%
2,074 $39,000
Q2 2021

Aug 16, 2021

SELL
$18.03 - $23.82 $5.89 Million - $7.78 Million
-326,685 Reduced 99.36%
2,089 $39,000
Q1 2021

May 13, 2021

BUY
$20.29 - $27.54 $4 Million - $5.42 Million
196,977 Added 149.45%
328,774 $7.48 Million
Q4 2020

Feb 12, 2021

BUY
$10.16 - $23.98 $1.34 Million - $3.16 Million
131,797 New
131,797 $2.86 Million
Q3 2020

Nov 12, 2020

SELL
$7.44 - $13.15 $27,699 - $48,957
-3,723 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$7.24 - $11.05 $26,954 - $41,139
3,723 New
3,723 $29,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $106M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.